Tritonpoint Wealth »

Immix Biopharma shares owned by Tritonpoint Wealth

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Tritonpoint Wealth from 13F filings

Historical chart of Tritonpoint Wealth investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Tritonpoint Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Tritonpoint Wealth

Quarter filed Position value Share count Share price at filing
2024-03-31 $170k 25k 6.92

More positions owned by Tritonpoint Wealth

Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Broadstone Net Lease (BNL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Growth Etf (VUG)
Danaher Corporation (DHR)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Accenture Plc Ireland Shs Class A (ACN)
United Parcel Service CL B (UPS)
Mastercard Incorporated Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Tritonpoint Wealth

Top funds holding Immix Biopharma

AIGH Capital Management
Cable Car Capital
Vanguard Group
Lynwood Capital Management
Geode Capital Management
Private Advisor
Susquehanna International
Corsair Capital Management
Millennium Management
Morgan Stanley
XTX Topco
Northern Trust
Tocqueville Asset Management
Imprint Wealth
Commonwealth Equity Services

View all funds holding Immix Biopharma